Cargando…
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
As the expression of a tumor associated antigen (TAA) is commonly not restricted to tumor cells, adoptively transferred T cells modified to express a conventional chimeric antigen receptor (CAR) might not only destroy the tumor cells but also attack target-positive healthy tissues. Furthermore, CAR...
Autores principales: | Mitwasi, Nicola, Feldmann, Anja, Bergmann, Ralf, Berndt, Nicole, Arndt, Claudia, Koristka, Stefanie, Kegler, Alexandra, Jureczek, Justyna, Hoffmann, Anja, Ehninger, Armin, Cartellieri, Marc, Albert, Susann, Rossig, Claudia, Ehninger, Gerhard, Pietzsch, Jens, Steinbach, Jörg, Bachmann, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752466/ https://www.ncbi.nlm.nih.gov/pubmed/29312553 http://dx.doi.org/10.18632/oncotarget.21017 |
Ejemplares similares
-
Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
por: Bachmann, Dominik, et al.
Publicado: (2017) -
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”
por: Feldmann, Anja, et al.
Publicado: (2017) -
An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells
por: Jureczek, Justyna, et al.
Publicado: (2019) -
A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR
por: Arndt, Claudia, et al.
Publicado: (2019) -
Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab(®)
por: Jureczek, Justyna, et al.
Publicado: (2020)